Migraine: open trials in Serbia

• NCT04965675

  A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  Trial Treatment · Phase 3 · H. Lundbeck A/S

  Univerzitetska Decija Klinika (UDK) (University Children's Hospital), Belgrade · Clinical Center Kragujevac, Kragujevac · University of Novi Sad - Faculty of Medicine - Clinical Center of Vojvodina - Hematology Clinic, Novi Sad · Institute of Child and Youth Health Care of Vojvodina, Novi Sad

  Registry updated 2026-10-16

• NCT05164172

  A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

  Trial Treatment · Phase 3 · H. Lundbeck A/S

  Univerzitetska Decija Klinika (UDK) (University Children's Hospital), Belgrade · Clinical Center Kragujevac, Kragujevac · University Clinical Center NIS, Niš · Institute of Child and Youth Health Care of Vojvodina, Novi Sad · University of Novi Sad - Faculty of Medicine - Clinical Center of Vojvodina - Hematology Clinic, Novi Sad

  Registry updated 2026-10-14

• NCT05897320

  A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

  Trial Treatment · Phase 3 · H. Lundbeck A/S

  Univerzitetska Decija Klinika (UDK) (University Children's Hospital), Belgrade · Clinical Center Kragujevac, Kragujevac · University Clinical Center NIS, Niš · Institute of Child and Youth Health Care of Vojvodina, Novi Sad · University of Novi Sad - Faculty of Medicine - Clinical Center of Vojvodina - Hematology Clinic, Novi Sad

  Registry updated 2026-10-14

All Migraine trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error